A NEW combination of drugs used to extend the lives of skin cancer patients has produced "very promising" results, experts say.The combination of the two drugs cobimetinib and Zelboraf has been trialled by patients being treated under the Royal Cornwall Hospitals Trust. The two medicines, which are both pills, work together to tackle the most deadly form of skin cancer. Survival data from the trial was announced at the Society for Melanoma Research (SMR) congress today.The results show...
